Adrenal Incidentalomas: When to Worry and When to Operate

Imagine going in for a routine CT scan to check on a kidney stone or a lung issue, only for your doctor to call you back and say they found a "spot" on your adrenal gland. You feel fine, you have no symptoms, but suddenly there is this unexpected mass. This is what doctors call an adrenal incidentaloma is a clinically unapparent adrenal mass larger than 1 cm discovered by chance during imaging for an unrelated reason. It's more common than you'd think-about 2% of the general population has one, and that number jumps to over 7% for people over 70.

The big question is: do you ignore it or cut it out? Most of the time, these masses are harmless. In fact, roughly 80% are benign non-functioning adenomas that don't need any treatment. However, a small slice of these cases are "functional," meaning they pump out hormones that can mess with your heart, blood pressure, and metabolism. Even worse, a tiny percentage are malignant. The goal of the evaluation process is to figure out which group you fall into without putting you through unnecessary surgery.

The Three Categories of Adrenal Masses

Not all adrenal growths are created equal. To decide on a treatment plan, doctors categorize these masses into three distinct buckets:

• Functioning Tumors: These are the "noisy" tumors. They overproduce hormones like aldosterone, cortisol, or adrenaline. While they might be benign in terms of cancer, their hormone output can cause severe health issues.
• Malignant Tumors: These include adrenocortical cancer or metastases (cancer that spread from another organ). These are rare-about 2-8% of cases-but they require urgent attention.
• Benign Non-functional Tumors: These are the "quiet" ones. They include simple adenomas, cysts, or myelolipomas (masses made of fat and bone marrow). These usually just sit there and do nothing.

How Doctors Evaluate the "Spot"

The evaluation process is a two-pronged attack: imaging to see what it looks like and biochemical tests to see what it's doing. You can't have one without the other.

The Imaging Phase

The first step is usually an unenhanced CT scan. Radiologists look at "attenuation values," measured in Hounsfield units (HU). If the value is below 10 HU, there is a 70-80% chance it's a benign adenoma. If the mass is irregular, has heterogeneous enhancement, or is growing rapidly (more than 1 cm a year), the red flags go up.

The Biochemical Phase

Even if a tumor looks benign on a scan, it could be secretly pumping out hormones. Doctors follow a strict screening protocol to rule out dangerous conditions:

1. Ruling out Pheochromocytoma: This is the non-negotiable first step. A pheochromocytoma is a tumor that secretes catecholamines (like adrenaline). If a surgeon operates on one of these without knowing, the patient can suffer a life-threatening hypertensive crisis on the operating table. Doctors check this using plasma-free metanephrines or 24-hour urinary tests.
2. Checking for Cortisol Excess: About 5% of these masses cause subclinical Cushing's syndrome. This is tested via a 1 mg dexamethasone suppression test. If your cortisol stays above 1.8 μg/dL after the test, your adrenal gland is acting autonomously.
3. Screening for Aldosterone: If you have high blood pressure or low potassium (hypokalemia), doctors will check your plasma aldosterone and renin levels to see if the tumor is causing primary hyperaldosteronism.

Surgical Criteria: When is it Time to Operate?

Surgery isn't a default; it's a targeted tool. There are very specific rules that trigger a referral to an adrenal surgeon.

The Size Rule: Size matters. Masses smaller than 4 cm are usually left alone if they are non-functional. However, once a mass hits the 4 cm mark, the risk of cancer increases. If the tumor is larger than 6 cm, the risk of it being an adrenocortical carcinoma jumps to about 25%.

The Function Rule: If the biochemical tests show the tumor is producing hormones-regardless of how small it is-it generally needs to come out. Whether it's an aldosterone-producing adenoma or a cortisol-secreting mass, the goal is to stop the hormonal chaos in your body.

The Growth Rule: If a follow-up scan shows the mass is growing quickly (e.g., doubling in volume within a year), surgery is warranted even if the hormone tests are normal. Rapid growth is a classic hallmark of malignancy.

Practical Risks and Pitfalls

The road to diagnosis can be stressful. Many patients report significant anxiety while waiting for test results, as the word "tumor" is scary. It's also important to know that not every hospital has the specialized tools needed for this. Only about 45% of community hospitals have immediate access to plasma metanephrine testing, which means you might need to visit a larger academic center for a proper workup.

Another pitfall is the "grey area" of subclinical hypercortisolism. Some patients have slightly elevated cortisol that doesn't cause obvious symptoms but increases their risk of heart disease and diabetes. This is currently one of the biggest debates in endocrinology: do we operate on a "quiet" tumor that is only slightly leaking cortisol? Recent evidence suggests that for those with serum cortisol levels over 5.0 μg/dL post-dexamethasone, surgery can actually improve metabolic health.

Managing the Process: Next Steps

If you've discovered an incidentaloma, don't panic. Your first move should be to ensure you have a multidisciplinary team. You need a radiologist to interpret the CT, an endocrinologist to run the biochemical screens, and a surgeon to evaluate the surgical risk.

If you are diagnosed with a pheochromocytoma, the preoperative phase is critical. You cannot go straight to surgery. You will need "alpha-blockade" medication for 7 to 14 days before the operation. This stabilizes your blood pressure and prevents a dangerous spike during anesthesia.